+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 75Years +
MALE
Healthy Volunteers
ID05448547

Study Comparing Immediate Curative Therapy Versus Conservative Treatment in Men 75 Years and Older with High-Risk Non-Metastatic Prostate Cancer Randomized Phase 3 Trial Measuring Survival and Quality of Life

Led by Sven Löffeler · Updated on 2026-09-10

980

Participants Needed

26

Research Sites

365 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating treatment options for older men aged 75 years or older with high-risk, non-metastatic prostate cancer. The study aims to compare immediate curative treatments like radiotherapy combined with hormone therapy or surgery to conservative approaches such as observation or hormone therapy. This trial addresses the uncertainty about whether immediate curative treatment offers survival benefits in older patients similar to those seen in younger men, while also considering quality of life and cost-effectiveness. Participants randomized to the immediate curative therapy group will receive either radiotherapy plus hormone therapy or surgery based on patient preference, with radiotherapy plus hormone therapy being the standard. Those assigned to the conservative group will be observed or receive hormone therapy depending on disease status, with further treatment given based on disease progression. This phase 3 randomized trial compares these two approaches over an extended period. Throughout the study, participants will be regularly evaluated for overall survival and disease burden up to 10 years after recruitment ends. Secondary assessments include monitoring urinary, bowel, and prostate cancer-related symptoms, quality of life, functional status, and the need for additional therapies. The study involves ongoing monitoring to understand long-term outcomes and side effects, supporting comprehensive assessment of treatment impact for this older population.

CONDITIONS

Brief Title

Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer

Research Team

S

Sven Loffeler, MD, PhD

E

Erik S Haug, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here